| Literature DB >> 30219191 |
Sanaz Katal1, Ali Gholamrezanezhad2, Michael Kessler3, Mojtaba Olyaei1, Hossein Jadvar4.
Abstract
Soft tissue sarcomas (STSs) account for less than 1% of adult solid tumors and about 7% of pediatric malignancies, causing 2% of cancer-related deaths. With the advent of PET-computed tomography (CT), the value of (18) fluorine-2-fluoro-2-deoxy-d-glucose (FDG) PET imaging to improve the management of STSs has been explored. FDG PET imaging has been found useful in restaging and treatment response assessment. This article reviews current knowledge and application of FDG PET-CT in initial diagnosis, staging, restaging, treatment response monitoring, and prognosis, with a brief overview of the most common histologic subtypes of STS.Entities:
Keywords: Angiosarcoma; Liposarcoma; Malignant fibrous histiocytoma; Malignant nerve sheath tumor; Pleomorphic undifferentiated sarcoma; Positron emission tomography; Rhabdomyosarcoma; Synovial cell sarcoma
Mesh：
Substances：
Year: 2018 PMID： 30219191 DOI： 10.1016/j.cpet.2018.05.011
Source DB: PubMed Journal: PET Clin ISSN： 1556-8598